Correction
This article was originally published in The Gray Sheet
Executive Summary
"The Gray Sheet" incorrectly reported in the June 28, 2010, issue that David Buckles, who has become acting ombudsman in the Center for Devices and Radiological Health, will occupy the spot vacated by Casper Uldriks. Buckles will in fact be filling the spot vacated by longtime ombudsman Les Weinstein (1"The Gray Sheet" April 12, 2010). Uldriks' former position as associate director for clinical research & government affairs within the Office of the Center Director is still vacant
You may also be interested in...
People In Brief
CDRH needs new ombudsman: Les Weinstein served his last day as ombudsman for FDA's device center April 9 and now moves to the same post within FDA's new Center for Tobacco Products. Weinstein was appointed as CDRH's first ombudsman in 2000 to handle complaints from outside the agency and disputes between the center and companies. CDRH has yet to name a replacement (1"The Gray Sheet" March 20, 2000). Weinstein released his final annual report for the device center April 7
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.